ORDER
REPRINTS
1302
GUTIERREZ, PRISBE, AND ROHLOFF
3. a) McKenna, C. E.; Schmidhauser, J. J. C. S. Chem. Commun. 1979, 739. b) McKenna,
C. E.; Higa, M. T.; Cheung, M. T.; McKenna, M.-C. Tetrahedron Lett. 1977, 155–158.
c) Rudinskas, A. J.; Hullar, T. L. J. Org. Chem. 1977, 42, 2771–2776.
4. a) Rabinowitz, R.; J. Org. Chem. 1963, 28, 2975–2978. b) Paulsen, H.; Thiem, J.
Chem. Ber. 1973, 106, 3850–3876.
5. Baer, E.; Robinson, R. Can. J. Chem. 1973, 51, 104–110. b) Paulsen, H.; Bartsch, W.
Chem. Ber. 1975, 108, 1732–1744.
6. a) Machida, Y.; Nomoto, S.; Saito, I. Synthetic Comm. 1979, 9, 97–102. b) Morita, T.;
Okamoto, Y.; Sakurai, H. Tetradedron Lett. 1978, 2523–2526.
7. Kluge, A. F.; Cloudsdale, I. S. J. Org. Chem. 1979, 44, 4847–4852.
8. a) Tsai, C.-C.; Folis, K. E.; Sabo, A.; Beck, T. W.; Grant, R. F.; Bischofberger, N.;
Benveniste, R. E.; Black, R. Science 1995, 270, 1197–1199. b) Naesens, L.; Balzarini,
J.; De Clercq, E. Rev. Med. Virol. 1995, 4, 147. c) Kim, C. U.; Luh, B. Y.; Misco, P. F.;
Bronson, J. J.; Hitchcock, M. J. M.; Ghazzouli, I.; Martin, J. C. J. Med. Chem. 1990,
33, 1207–1213. d) Bronson, J. J.; Kim, C. U.; Ghazzouli, I.; Hitchcock, M. J. M.;
Kern, E.; Martin, J. C. Nucleosides and Antiviral Agents; Martin, J. C., Ed.; American
Chemical Society, Washington, DC, 1989, 72–87. e) Starret, J. E. Jr.; Tortolani, D. R.;
Russell, J.; Hitchcock, M. J. M.; Whiterock, V.; Martin, J. C.; Mansuri, M. M. J. Med.
Chem. 1994, 37, 1857–1864. f) Balzarini, J.; Aquaro, S.; Perno, C. F.; Witvrouw, M.;
Holy, A.; DeClercq, E. Biochem. Biophys. Res. Commun. 1996, 219, 337.
9. Schultz, L. M.; Chapman, H. H.; Dupree, N. J.; Jones, R. J.; Kent, K. M.; Lee, T. T.;
Louie, M. J.; Postich, M. J.; Prisbe, E. J.; Rohloff, J. C.; Yu, R. H. Tetrahedron Lett.
1998, 39, 1853–1856.
10. General procedure for cleavage of dialkyl phosphonates – preparation of 6: Diethyl
PMEA 4 (9) (41.1 g, 0.125 mol) and chlorobenzene (0.125 L) were charged to a 1 L
ACETM glass pressure reactor containing a thermowell and a pressure gauge. The
contents were stirred while TMSCl (56 mL, 0.44 mol) was added slowly. The reaction
vessel was purged with N2, sealed, and heated to 125◦C. The internal reactor pressure
increased incrementally to a maximum of 30 psi after 9 h. The contents were cooled
to r.t. at which time the pressure returned to ambient pressure and water (160 mL) was
added with vigorous stirring. The layers were separated and the lower aqueous layer
containing the product was collected. The aqueous layer was adjusted to pH = 3.2
with 25% NaOH (∼36 g), the resulting slurry cooled to 0◦C and the solid collected by
vacuum filtration. Water (40 mL) was added to the wet cake, the resulting slurry was
heated to 70◦C for 1 h, and then cooled to 0◦C. The solid product was collected by vac-
uum filtration and dried under vacuum (50◦C/28 mmHg) affording 33.0 g (0.120 mol,
96%) PMEA 6. NMR data for PMEA 6 was consistent with literature values. Holy,
A.; Rosenberg, I. Collect. Czech. Chem. Commun. 1987, 52, 2801–2809.
11. In the same manner as above 48.3 g (0.140 mol) diethyl PMPA 5 (9) were depro-
tected with 4.5 equiv. TMSCl and yielded 30.3 g (0.105 mol, 75%) of PMPA 7 (99%
pure by quantitative HPLC assay versus an external standard). 1H NMR (300 MHz,
D2O, δ): 8.31 (s, 2H, Adenine–2H, –8H), 4.39 (dd, J = 14, 3 Hz, 1H, –CH2N), 4.20
(dd, J = 14, 7 Hz, 1H, –CH2N), 3.89 (m, 1H, –CH–), 3.58 (dd, J = 13, 9 Hz, 1H,
–OCH2P), 3.38 (dd, J = 13, 9 Hz, 1H, –OCH2P), 1.07 (d, J = 6 Hz, 3H, –CH3) 31
NMR (121 MHz, D2O, δ): 15.79.
P
12. Hampton, A.; Sasaki, T.; Paul, B. J. Am. Chem. Soc. 1973, 95, 4404–4414.